8-K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): May 6, 2010

AMERICAN PACIFIC CORPORATION

(Exact name of registrant as specified in its charter)

Delaware	1-8137	59-6490478
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

3883 Howard Hughes Parkway, Suite 700, Las Vegas, Nevada 89169

(Address of principal executive offices)	(Zip Code)
Registrant’s telephone number, including area code:	(702) 735-2200

N/A
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 2.02 Results of Operations and Financial Condition.

     On May 6, 2010, the Registrant issued a press release relating to the Registrant’s earnings for the fiscal 2010 second quarter ended March 31, 2010. A copy of the press release is attached hereto as Exhibit 99.1.

     The information in this report (including Exhibit 99.1) is being furnished pursuant to Item 2.02 and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act.

Item 9.01 Financial Statements and Exhibits.

     (c) Exhibits.

     99.1   Press release of American Pacific Corporation, dated May 6, 2010.

- 1 -

SIGNATURE

     Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	American Pacific Corporation
Date: May 6, 2010	By:	/s/ JOSEPH CARLEONE
		Joseph Carleone
		President and Chief Executive Officer

- 2 -

EXHIBIT INDEX

Exhibit No.	Description
99.1	Press release of American Pacific Corporation, dated May 6, 2010.

EX-99.1

EXHIBIT 99.1

AMERICAN PACIFIC – News Release
Contact: Dana M. Kelley – (702) 735-2200
E-mail: InvestorRelations@apfc.com
Website: www.apfc.com

AMERICAN PACIFIC REPORTS FISCAL 2010
SECOND QUARTER RESULTS

LAS VEGAS, NEVADA, May 6, 2010 — American Pacific Corporation (NASDAQ: APFC) today reported financial results for its fiscal 2010 second quarter ended March 31, 2010.

We provide non-GAAP measures as a supplement to financial results based on GAAP. A reconciliation of the non-GAAP measures to the most directly comparable GAAP measures is included in the accompanying supplemental data.

FINANCIAL SUMMARY

Quarter Ended March 31, 2010 Compared to Quarter Ended March 31, 2009

• Revenues increased $3.0 million, or 5%, to $59.4 million from $56.4 million.

• Operating income was $5.4 million compared to operating income of $6.2 million.

• Adjusted EBITDA was $9.4 million compared to $10.3 million.

• Net income was $1.1 million compared to $1.7 million.

• Diluted earnings per share was $0.15 compared to $0.23.

Six Months Ended March 31, 2010 Compared to Six Months Ended March 31, 2009

• Revenues decreased $8.6 million, or 8%, to $93.5 million from $102.1 million.

• Operating income was $5.6 million compared to operating income of $9.7 million.

• Adjusted EBITDA was $14.0 million compared to $17.9 million.

• Net loss was $0.3 million compared to net income of $2.2 million.

• Diluted loss per share was $0.04 compared to diluted earnings per share of $0.29.

CONSOLIDATED RESULTS OF OPERATIONS

Revenues – For our second quarter of the fiscal year ending September 30, 2010 (“Fiscal 2010”), revenues increased 5% to $59.4 million as compared to the second quarter of the fiscal year ended September 30, 2009 (“Fiscal 2009”), reflecting increases of 43% and 6% for our Aerospace Equipment segment and Fine Chemicals segment revenues, respectively, offset by a decrease of 18% in Specialty Chemicals segment revenues. For the Fiscal 2010 six-month period, revenues decreased 8% to $93.5 million as compared to the Fiscal 2009 six-month period, reflecting an increase of 43% for our Aerospace Equipment segment revenues, offset by decreases of 17% and 22% in Fine Chemicals segment and Specialty Chemicals segment revenues, respectively.

See further discussion under Segment Highlights.

Cost of Revenues and Gross Margins – For our Fiscal 2010 second quarter, cost of revenues was $42.5 million compared to $39.1 million for the prior fiscal year second quarter. The consolidated gross margin percentage was 28% and 31% for our Fiscal 2010 and Fiscal 2009 second quarters, respectively. For the Fiscal 2010 six-month period, cost of revenues was $64.1 million compared to $70.0 million for the prior fiscal year six-month period. The consolidated gross margin percentage was 31% for both the Fiscal 2010 and Fiscal 2009 six-month periods.

– more –

3883 HOWARD HUGHES • PARKWAY SUITE 700 • LAS VEGAS, NV 89169
PHONE (702) 735-2200 • FAX (702) 735-4876

Page 1 of Exhibit 99.1

One of the most significant factors that affects, and should continue to affect, the comparison of our consolidated gross margins from period to period is the change in revenue mix between our segments. The revenue contribution by each of our segments is indicated in the following table.

	Three Months Ended						Six Months Ended
	March 31,						March 31,
	2010			2009			2010			2009
Fine Chemicals		57	%		56	%		46	%		51	%
Specialty Chemicals		24	%		31	%		29	%		34	%
Aerospace Equipment		17	%		13	%		20	%		13	%
Other Businesses		2	%		0	%*		5	%		2	%
Total Revenues		100	%		100	%		100	%		100	%

* less than 1%

In addition, consolidated gross margins for our Fiscal 2010 periods reflect:

• An increase in Fine Chemicals segment gross margin percentage primarily because manufacturing inefficiencies in the Fiscal 2009 periods did not recur in the Fiscal 2010 periods.

• A decline in Aerospace Equipment segment gross margin percentage primarily due to increases in the estimated costs to complete certain of its systems contracts.

See further discussion under Segment Highlights.

Operating Expenses – For our Fiscal 2010 second quarter, operating expenses increased $0.3 million to $11.4 million from $11.1 million for the prior fiscal year second quarter. The most significant components of the net increase include:

• An increase in Aerospace Equipment segment operating expenses of $0.6 million primarily due to additional management and organization structure which was added to support the segment’s European growth strategy.

• A decrease in corporate expenses primarily related to reduced strategic development costs.

For our Fiscal 2010 six-month period, operating expenses increased $1.4 million to $23.8 million from $22.4 million for the prior fiscal year six-month period primarily due to an increase in Aerospace Equipment segment operating expenses for management and organization structure which was added to support the segment’s European growth strategy.

SEGMENT HIGHLIGHTS

Fine Chemicals Segment

Our Fine Chemicals segment reflects the operating results of our wholly-owned subsidiary Ampac Fine Chemicals LLC (“AFC”).

Quarter Ended March 31, 2010 Compared to Quarter Ended March 31, 2009

• Revenues were $33.7 million compared to revenues of $31.7 million.

• Operating income was $2.5 million compared to $1.4 million.

• Segment EBITDA was $5.7 million, or 17% of segment revenues, compared to Segment EBITDA of $4.5 million, or 14% of segment revenues.

- more -

Page 2 of Exhibit 99.1

Six Months Ended March 31, 2010 Compared to Six Months Ended March 31, 2009

• Revenues were $43.2 million compared to revenues of $52.1 million.

• Operating income was $1.8 million compared to $0.4 million.

• Segment EBITDA was $8.3 million, or 19% of segment revenues, compared to Segment EBITDA of $6.7 million, or 13% of segment revenues.

The increase in Fine Chemicals segment revenues for the Fiscal 2010 second quarter compared to the prior fiscal year second quarter is primarily due to the timing of customer orders, and the resulting revenues, between our fiscal year quarterly periods.

The decrease in Fine Chemicals segment revenues for the Fiscal 2010 six-month period reflects reductions in orders for core products in each of our three primary therapeutic areas. The decline in segment revenues for the first half of Fiscal 2010 is consistent with our expectation that annual Fiscal 2010 revenues for this segment will decline in the range of 15% as compared to Fiscal 2009.

Operating income and Segment EBITDA for the Fiscal 2010 periods improved both in dollars and as a percentage of segment revenues, as compared to the prior fiscal year periods. The gross margin percentage improved by three points for the Fiscal 2010 second quarter and seven points for the Fiscal 2010 six-month period. The primary reason for the improvement is that manufacturing inefficiencies that affected the Fiscal 2009 periods did not recur in the Fiscal 2010 periods. Fine Chemicals segment operating expenses increased by approximately $0.3 million for both the Fiscal 2010 second quarter and six-month period primarily due to an increase in business development activities.

Recent AFC News:

• AFC partnered with Codexis, Inc. to provide AFC access to certain of Codexis’ biocatalysts that add to the technologies already available at AFC.

• Inabata & Co., Ltd. was announced as AFC’s exclusive agent in the country of Japan.

• AFC expanded its manufacturing capacity through the purchase of a Fine Chemical facility in La Porte, Texas.

Specialty Chemicals Segment

Our Specialty Chemicals segment revenues include the operating results from our perchlorate, sodium azide and Halotron product lines, with perchlorates comprising 89% and 92% of Specialty Chemicals segment revenues in Fiscal 2010 and Fiscal 2009 six-month periods, respectively.

Quarter Ended March 31, 2010 Compared to Quarter Ended March 31, 2009

• Revenues decreased to $14.1 million from $17.3 million.

• Operating income was $6.5 million, or 46% of segment revenues, compared to $8.3 million, or 48% of segment revenues.

• Segment EBITDA was $6.9 million, or 49% of segment revenues, compared to $8.6 million, or 50% of segment revenues.

Six Months Ended March 31, 2010 Compared to Six Months Ended March 31, 2009

• Revenues decreased to $26.9 million from $34.6 million.

• Operating income was $12.3 million, or 46% of segment revenues, compared to $15.9 million, also 46% of segment revenues.

• Segment EBITDA was $12.9 million, or 48% of segment revenues, compared to $16.6 million, also 48% of segment revenues.

- more -

Page 3 of Exhibit 99.1

The variances in Specialty Chemicals segment revenues reflect the following factors:

• A 29% decrease in perchlorate volume offset by a 13% increase in the related average price per pound for the Fiscal 2010 second quarter compared to the prior fiscal year second quarter.

• A 38% decrease in perchlorate volume offset by a 20% increase in the related average price per pound for the Fiscal 2010 six-month period compared to the prior fiscal year six-month period.

• Sodium azide revenues increased $0.5 million for the Fiscal 2010 six-month period, compared to the prior fiscal year six-month period, reflecting increased sales outside the U.S.

• Halotron revenues were consistent between comparable second quarter and six-month periods.

The decreases in volume for the Fiscal 2010 second quarter and six-month period are consistent with our expectation that total perchlorate volume for Fiscal 2010 is anticipated to decline by approximately 50% compared to the prior fiscal year. The increases in average prices per pound reflect two offsetting factors:

• The average price per pound of Grade I ammonium perchlorate (“AP”) increased approximately proportionate and inverse to the decrease in Grade I AP volume consistent with the contractual Grade I AP price-volume matrix and comparable in catalog pricing.

• This was offset, in part, by our other lower-priced perchlorate products, such as sodium perchlorate and potassium perchlorate, which accounted for a greater percentage of all perchlorate product volume in the Fiscal 2010 periods. This change in the mix of perchlorate product sales had the effect of reducing the average price per pound of all perchlorate products.

Strategic and tactical missile programs accounted for the significant portion of perchlorate revenues in the Fiscal 2010 second quarter. In addition to the Fiscal 2010 second quarter activity, perchlorate revenues for the Fiscal 2010 six-month period include space related programs, primarily the Ares program. For the Fiscal 2009 second quarter and six-month period, the greatest contributor to segment revenues was product for the Space Shuttle Reusable Solid Rocket Motor (“RSRM”) program.

Specialty Chemicals segment operating income as a percentage of segment revenues was consistent between Fiscal 2010 and the prior fiscal year for both the second quarter and the six-month period. Lower manufacturing volume in Fiscal 2010 and the related effects on unit cost of fixed manufacturing overhead have resulted in increases in manufacturing cost of AP per pound. These cost increases are consistent with the related price increases, and as a result, operating margin percentages have been maintained.

Operating expenses decreased $0.1 million for the Fiscal 2010 second quarter and $0.3 million for the Fiscal 2010 six-month period primarily due to decreases in employee related costs.

Aerospace Equipment Segment

Our Aerospace Equipment segment reflects the operating results of our wholly-owned subsidiary Ampac-ISP Corp. and its wholly-owned subsidiaries.

Quarter Ended March 31, 2010 Compared to Quarter Ended March 31, 2009

• Revenues increased 43% to $10.2 million from $7.1 million.

• Operating profit was breakeven compared to operating income of $0.7 million.

• Segment EBITDA was $0.4 million compared to $1.1 million.

Six Months Ended March 31, 2010 Compared to Six Months Ended March 31, 2009

• Revenues increased 43% to $18.5 million from $12.9 million.

• Operating loss was $0.3 million compared to operating income of $1.2 million.

• Segment EBITDA was $0.5 million compared to $1.8 million.

- more -

Page 4 of Exhibit 99.1

Aerospace Equipment segment revenues increased 43% for both the Fiscal 2010 second quarter and six-month period as compared to each of the prior fiscal year periods. Revenue growth for the Fiscal 2010 second quarter and six-month period was driven by revenues for in-space propulsion engines which increased primarily due to the high volume of material receipts in the Fiscal 2010 second quarter. We expect that Aerospace Equipment segment revenues for the full Fiscal 2010 year will grow by at least 10% compared to the prior fiscal year.

Operating profit and Segment EBITDA declined as a percentage of segment revenues for both the Fiscal 2010 second quarter and six-month periods. The gross margin percentage declined by eleven points in the Fiscal 2010 six-month period attributed primarily to increases in estimated costs to complete certain systems contracts. Aerospace Equipment segment operating expenses increased $1.2 million primarily as a result of additional management and organization structure which was added to support the segment’s European growth strategy.

Our European growth strategy includes further development of our relationship with the Irish government. In recent months, our European operations secured a funded project for valve development.

CAPITAL AND LIQUIDITY HIGHLIGHTS

Liquidity – As of March 31, 2010, we had cash balances of $32.5 million and no cash borrowings against our $20.0 million revolving credit line. In addition, we were in compliance with the various covenants contained in our credit agreements.

Operating Cash Flows – Operating activities provided cash of $14.6 million for the Fiscal 2010 six-month period compared to $14.2 million for the prior fiscal year six-month period, resulting in an increase of $0.4 million.

Significant components of the change in cash flow from operating activities include:

• A decrease in cash provided by Adjusted EBITDA of $3.9 million.

• An increase in cash provided by working capital accounts of $4.4 million, excluding the effects of interest and income taxes.

• An increase in cash taxes refunded of $0.2 million.

• An increase in cash used for environmental remediation of $0.3 million.

The increase in cash provided by working capital accounts for the Fiscal 2010 six-month period is primarily due to timing. We consider these working capital changes to be routine and within the normal production cycle of our products. The production of most fine chemical products requires a length of time that exceeds one quarter. In addition, the timing of Aerospace Equipment segment revenues recognized under the percentage-of-completion method differs from the timing of the related billings to customers. Therefore, in any given quarter, accounts receivable, work-in-progress inventory or deferred revenues can increase or decrease significantly. We expect that our working capital may vary normally by as much as $10.0 million from quarter to quarter.

Investing Cash Flows – Capital expenditures decreased by $0.8 million in the Fiscal 2010 six-month period compared to the prior fiscal year six-month period due to the timing of expenditures. Capital expenditures in both periods were primarily maintenance capital related.

OUTLOOK

We are updating our guidance for Fiscal 2010. We expect consolidated revenues of at least $180.0 million and Adjusted EBITDA to range from $26.0 million to $28.0 million. The low end of our Fiscal 2010 guidance for Adjusted EBITDA is computed by adding estimated amounts for depreciation and amortization of $16.0 million, interest expense of $11.0 million, share-based compensation expense of $1.0 million and income tax benefit of $1.0 to estimated net loss of $1.0 million. We are anticipating our capital expenditures, which do not include environmental remediation spending, for Fiscal 2010 to range from approximately $10.0 million to approximately $14.0 million.

- more -

Page 5 of Exhibit 99.1

The changes in our guidance primarily reflect our updated expectation that Fine Chemicals segment revenues will decline by approximately 15% in Fiscal 2010 as compared to Fiscal 2009, and the corresponding effects on Adjusted EBITDA and net loss.

Change in Accounting Standard. Effective October 1, 2009, we adopted a revised accounting standard that requires us to expense acquisition related costs, such as legal fees, when incurred. Under the previous accounting standard, these costs were included in the total cost of an acquisition and capitalized. Our Fiscal 2010 guidance for Adjusted EBITDA includes no amounts for acquisition related costs. Accordingly, should we pursue an acquisition, direct costs associated with that action would be incremental to our guidance.

INVESTOR TELECONFERENCE

We invite you to participate in a teleconference with our executive management covering our Fiscal 2010 second quarter financial results. The investor teleconference will be held Thursday, May 6, 2010 at 1:30 p.m., Pacific Daylight Time. The teleconference will include a presentation by management followed by a question and answer session. The teleconference can be accessed by dialing 866-788-0544 between 1:15 and 1:30 p.m., Pacific Daylight Time. Please reference passcode #72994698. As is our customary practice, a live webcast of the teleconference is being provided by Thomson Reuters. A link to the webcast and the earnings release is available at our website at www.apfc.com, and will be available for replay until a few days before our next quarterly investor teleconference.

RISK FACTORS/FORWARD-LOOKING STATEMENTS

The unaudited financial results included in this release are preliminary. Statements contained in this earnings release that are not purely historical are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including without limitation the statement regarding one of the significant factors that will affect comparisons of our consolidated gross margins in the future, the statement regarding anticipated Fiscal 2010 Fine Chemicals segment revenues, the statement regarding the anticipated total volume of perchlorate products to be sold in Fiscal 2010, the statement regarding anticipated Fiscal 2010 revenues for our Aerospace Equipment segment, statements regarding our working capital changes and future variations, and statements in the “Outlook” section of this earnings release. Words such as “anticipate”, “expect”, “should”, “may”, “can” and similar expressions are intended to identify forward-looking statements. The inclusion of forward-looking statements should not be regarded as a representation by us that any of our expectations will be achieved. Actual results may differ materially from future results or outcomes expressed or implied by forward-looking statements set forth in the release due to risks, uncertainties and other important factors inherent in our business. Factors that might cause actual results to differ include, but are not limited to, the following:

• We depend on a limited number of customers for most of our sales in our Specialty Chemicals, Aerospace Equipment and Fine Chemicals segments and the loss of one or more of these customers could have a material adverse effect on our financial position, results of operations and cash flows.

• The inherent limitations of our fixed-price or similar contracts may impact our profitability.

• The numerous and often complex laws and regulations and regulatory oversight to which our operations and properties are subject, the cost of compliance, and the effect of any failure to comply could reduce our profitability and liquidity.

• A significant portion of our business depends on contracts with the government or its prime contractors or subcontractors and these contracts are impacted by governmental priorities and are subject to potential fluctuations in funding or early termination, including for convenience, any of which could have a material adverse effect on our operating results, financial condition or cash flows.

• We may be subject to potentially material costs and liabilities in connection with environmental or health matters.

- more -

Page 6 of Exhibit 99.1

• Although we have established an environmental reserve for remediation activities in Henderson, Nevada, given the many uncertainties involved in assessing environmental liabilities, our environmental-related risks may from time to time exceed any related reserves.

• For each of our Specialty Chemicals, Fine Chemicals and Aerospace Equipment segments, most production is conducted in a single facility and any significant disruption or delay at a particular facility could have a material adverse effect on our business, financial position and results of operations.

• The release or explosion of dangerous materials used in our business could disrupt our operations and cause us to incur additional costs and liabilities.

• Disruptions in the supply of key raw materials and difficulties in the supplier qualification process, as well as increases in prices of raw materials, could adversely impact our operations.

• Each of our Specialty Chemicals, Fine Chemicals and Aerospace Equipment segments may be unable to comply with customer specifications and manufacturing instructions or may experience delays or other problems with existing or new products, which could result in increased costs, losses of sales and potential breach of customer contracts.

• Successful commercialization of pharmaceutical products and product line extensions is very difficult and subject to many uncertainties. If a customer is not able to successfully commercialize its products for which AFC produces compounds or if a product is subsequently recalled, then the operating results of AFC may be negatively impacted.

• A strike or other work stoppage, or the inability to renew collective bargaining agreements on favorable terms, could have a material adverse effect on the cost structure and operational capabilities of AFC.

• The pharmaceutical fine chemicals industry is a capital-intensive industry and if AFC does not have sufficient financial resources to finance the necessary capital expenditures, its business and results of operations may be harmed.

• We may be subject to potential liability claims for our products or services that could affect our earnings and financial condition and harm our reputation.

• Technology innovations in the markets that we serve may create alternatives to our products and result in reduced sales.

• We are subject to strong competition in certain industries in which we participate and therefore may not be able to compete successfully.

• Due to the nature of our business, our sales levels may fluctuate causing our quarterly operating results to fluctuate.

• The inherent volatility of the chemical industry affects our capacity utilization and causes fluctuations in our results of operations.

• A loss of key personnel or highly skilled employees, or the inability to attract and retain such personnel, could disrupt our operations or impede our growth.

• We may continue to expand our operations in part through acquisitions, which could divert management’s attention and expose us to unanticipated liabilities and costs. We may experience difficulties integrating the acquired operations, and we may incur costs relating to acquisitions that are never consummated.

• We have a substantial amount of debt, and the cost of servicing that debt could adversely affect our ability to take actions, our liquidity or our financial condition.

• If we are unable to generate sufficient cash flow to service our debt and fund our operating costs, our liquidity may be adversely affected.

• Significant changes in discount rates, rates of return on pension assets, mortality tables and other factors could affect our estimates of pension obligations, which in turn could affect future funding requirements and related costs and impact our future earnings.

• Our shareholder rights plan, Restated Certificate of Incorporation, as amended, and Amended and Restated By-laws discourage unsolicited takeover proposals and could prevent stockholders from realizing a premium on their common stock.

- more -

Page 7 of Exhibit 99.1

• Our proprietary and intellectual property rights may be violated, compromised, circumvented or invalidated, which could damage our operations.

• Our common stock price may fluctuate substantially, and a stockholder’s investment could decline in value.

Readers of this earnings release are referred to our Annual Report on Form 10-K for Fiscal 2009, our Quarterly Report on Form 10-Q for the quarter ended December 31, 2009 and our other filings with the Securities and Exchange Commission for further discussion of these and other factors that could affect our future results. The forward-looking statements contained in this earnings release are made as of the date hereof and we assume no obligation to update for actual results or to update the reasons why actual results could differ materially from those projected in the forward-looking statements, except as required by law. In addition, the operating results for the quarter and six months ended March 31, 2010 and cash flows for the six months ended March 31, 2010 are not necessarily indicative of the results that will be achieved for future periods.

ABOUT AMERICAN PACIFIC CORPORATION

American Pacific Corporation (AMPAC) is a leading custom manufacturer of fine chemicals, specialty chemicals and propulsion products within its focused markets. We supply active pharmaceutical ingredients and advanced intermediates to the pharmaceutical industry. For the aerospace and defense industry we provide specialty chemicals used in solid rocket motors for space launch and military missiles. AMPAC also designs and manufactures liquid propulsion systems, valves and structures for space and missile defense applications. We produce clean agent chemicals for the fire protection industry, as well as electro-chemical equipment for the water treatment industry. Our products are designed to meet customer specifications and often must meet certain governmental and regulatory approvals. Additional information about us can be obtained by visiting our web site at www.apfc.com.

- more -

Page 8 of Exhibit 99.1

AMERICAN PACIFIC CORPORATION
Condensed Consolidated Statements of Operations
(Unaudited, Dollars in Thousands, Except per Share Amounts)

	Three Months Ended						Six Months Ended
	March 31,						March 31,
	2010			2009			2010			2009
Revenues	$	59,395		$	56,435		$	93,459		$	102,064
Cost of Revenues		42,516			39,138			64,134			70,033
Gross Profit		16,879			17,297			29,325			32,031
Operating Expenses		11,444			11,071			23,751			22,380
Operating Income		5,435			6,226			5,574			9,651
Interest and Other Income (Expense), Net		(260	)		(19	)		(268	)		42
Interest Expense		2,740			2,684			5,431			5,378
Income (Loss) before Income Tax		2,435			3,523			(125	)		4,315
Income Tax Expense		1,319			1,790			199			2,125
Net Income (Loss)	$	1,116		$	1,733		$	(324	)	$	2,190
Earnings (Loss) per Share:
Basic	$	0.15		$	0.23		$	(0.04	)	$	0.29
Diluted	$	0.15		$	0.23		$	(0.04	)	$	0.29
Weighted Average Shares Outstanding:
Basic		7,490,000			7,483,000			7,489,000			7,481,000
Diluted		7,539,000			7,522,000			7,489,000			7,545,000

- more -

Page 9 of Exhibit 99.1

AMERICAN PACIFIC CORPORATION
Condensed Consolidated Balance Sheets
(Unaudited, Dollars in Thousands, Except per Share Amounts)

	March 31,			September 30,
	2010			2009
ASSETS
Current Assets:
Cash and Cash Equivalents	$	32,514		$	21,681
Accounts Receivable, Net		41,468			44,028
Inventories		36,430			36,356
Prepaid Expenses and Other Assets		2,391			1,811
Income Taxes Receivable		1,467			2,148
Deferred Income Taxes		6,317			6,317
Total Current Assets		120,587			112,341
Property, Plant and Equipment, Net		111,148			114,645
Intangible Assets, Net		2,418			3,553
Goodwill		2,899			3,144
Deferred Income Taxes		21,124			21,121
Other Assets		10,420			10,037
TOTAL ASSETS	$	268,596		$	264,841
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current Liabilities:
Accounts Payable	$	8,868		$	7,444
Accrued Liabilities		6,319			5,295
Accrued Interest		1,650			1,650
Employee Related Liabilities		5,600			6,930
Income Taxes Payable		397			189
Deferred Revenues and Customer Deposits		9,208			6,911
Current Portion of Environmental Remediation Reserves		2,101			2,522
Current Portion of Long-Term Debt		112			151
Total Current Liabilities		34,255			31,092
Long-Term Debt		110,135			110,097
Environmental Remediation Reserves		23,610			24,168
Pension Obligations		29,120			27,720
Other Long-Term Liabilities		596			667
Total Liabilities		197,716			193,744
Commitments and Contingencies
Shareholders’ Equity
Preferred Stock — $1.00 par value; 3,000,000 authorized; none outstanding		—			—
Common Stock — $0.10 par value; 20,000,000 shares authorized, 7,540,591 and 7,504,591 issued		754			750
Capital in Excess of Par Value		72,807			72,322
Retained Earnings		9,673			9,997
Accumulated Other Comprehensive Loss		(12,354	)		(11,972	)
Total Shareholders’ Equity		70,880			71,097
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$	268,596		$	264,841

- more -

Page 10 of Exhibit 99.1

AMERICAN PACIFIC CORPORATION
Condensed Consolidated Statements of Cash Flow
(Unaudited, Dollars in Thousands)

	Six Months Ended
	March 31,
	2010			2009
Cash Flows from Operating Activities:
Net Income (Loss)	$	(324	)	$	2,190
Adjustments to Reconcile Net Income (Loss) to Net Cash Provided by Operating Activities:
Depreciation and amortization		8,176			7,870
Non-cash interest expense		315			315
Share-based compensation		489			305
Excess tax benefit from stock option exercises		—			(3	)
Deferred income taxes		(81	)		(68	)
Loss on sale of assets		5			53
Changes in operating assets and liabilities:
Accounts receivable, net		2,375			(1,220	)
Inventories		(136	)		5,058
Prepaid expenses and other current assets		(591	)		1,019
Accounts payable		1,395			(3,032	)
Income taxes		900			2,502
Accrued liabilities		1,039			287
Accrued interest		—			—
Employee related liabilities		(1,457	)		(2,125	)
Deferred revenues and customer deposits		2,418			625
Environmental remediation reserves		(979	)		(717	)
Pension obligations, net		1,546			1,008
Other		(496	)		85
Net Cash Provided by Operating Activities		14,594			14,152
Cash Flows from Investing Activities:
Capital expenditures		(3,588	)		(4,412	)
Acquisition of business, net of cash acquired		—			(6,661	)
Net Cash Used by Investing Activities		(3,588	)		(11,073	)
Cash Flows from Financing Activities:
Payments of long-term debt		(89	)		(172	)
Issuances of common stock, net		—			32
Excess tax benefit from stock option exercises		—			3
Net Cash Used by Financing Activities		(89	)		(137	)
Effect of Changes in Currency Exchange Rates on Cash		(84	)		—
Net Change in Cash and Cash Equivalents		10,833			2,942
Cash and Cash Equivalents, Beginning of Period		21,681			26,893
Cash and Cash Equivalents, End of Period	$	32,514		$	29,835

- more -

Page 11 of Exhibit 99.1

AMERICAN PACIFIC CORPORATION
Supplemental Data
(Unaudited, Dollars in Thousands)

	Three Months Ended						Six Months Ended
	March 31,						March 31,
	2010			2009			2010			2009
Operating Segment Data:
Revenues:
Fine Chemicals	$	33,673		$	31,738		$	43,177		$	52,122
Specialty Chemicals		14,086			17,283			26,889			34,641
Aerospace Equipment		10,168			7,135			18,493			12,892
Other Businesses		1,468			279			4,900			2,409
Total Revenues	$	59,395		$	56,435		$	93,459		$	102,064
Segment Operating Income (Loss):
Fine Chemicals	$	2,500		$	1,406		$	1,760			$382
Specialty Chemicals		6,513			8,325			12,344			15,931
Aerospace Equipment		25			743			(337	)		1,153
Other Businesses		69			(167	)		52			378
Total Segment Operating Income		9,107			10,307			13,819			17,844
Corporate Expenses		(3,672	)		(4,081	)		(8,245	)		(8,193	)
Operating Income	$	5,435		$	6,226		$	5,574		$	9,651
Depreciation and Amortization:
Fine Chemicals	$	3,194			3,136		$	6,522			6,344
Specialty Chemicals		406			323			577			627
Aerospace Equipment		392			323			815			654
Other Businesses		4			3			8			6
Corporate		127			116			254			239
Total Depreciation and Amortization	$	4,123		$	3,901		$	8,176		$	7,870
Segment EBITDA (a):
Fine Chemicals	$	5,694		$	4,542		$	8,282		$	6,726
Specialty Chemicals		6,919			8,648			12,921			16,558
Aerospace Equipment		417			1,066			478			1,807
Other Businesses		73			(164	)		60			384
Total Segment EBITDA		13,103			14,092			21,741			25,475
Less: Corporate Expenses, Excluding Depreciation		(3,545	)		(3,965	)		(7,991	)		(7,954	)
Plus: Share-based Compensation		143			173			489			305
Plus: Interest and Other Income, Net		(260	)		(19	)		(268	)		42
Adjusted EBITDA (b)	$	9,441		$	10,281		$	13,971		$	17,868
Reconciliation of Net Income (Loss) to Adjusted EBITDA (b):
Net Income (Loss)	$	1,116		$	1,733		$	(324	)	$	2,190
Add Back:
Income Tax Expense		1,319			1,790			199			2,125
Interest Expense		2,740			2,684			5,431			5,378
Depreciation and Amortization		4,123			3,901			8,176			7,870
Share-based Compensation		143			173			489			305
Adjusted EBITDA	$	9,441		$	10,281		$	13,971		$	17,868

(a)	Segment EBITDA is defined as segment operating income (loss) plus depreciation and amortization.
(b)	Adjusted EBITDA is defined as net income (loss) before income tax expense (benefit), interest expense, depreciation and amortization, share-based compensation and environmental remediation charges (if any).

Segment EBITDA and Adjusted EBITDA are not financial measures calculated in accordance with GAAP and should not be considered as an alternative to income (loss) from operations as performance measures. Each EBITDA measure is presented solely as a supplemental disclosure because management believes that each is a useful performance measure that is widely used within the industries in which we operate. In addition, EBITDA measures are significant measurements for covenant compliance under our revolving credit facility. Each EBITDA measure is not calculated in the same manner by all companies and, accordingly, may not be an appropriate measure for comparison.

# # #

Page 12 of Exhibit 99.1